Logo of Al Razi Medical Co.
Al Razi Medical Co. issued today, May 7, its prospectus to float 304,000 shares, or 20% of its SAR 15.2 million capital, on Nomu-Parallel Market.
The share sale will run from June 4-6 for qualified investors.
The offering will be confined to qualified investors stipulated in the glossary of defined terms used in the regulations and rules of the Capital Market Authority (CMA).
Al Razi Medical is a closed Saudi joint stock company, established as a sole proprietorship in 2006. It is headquartered in Al Badayea city.
The company’s activity, as per its commercial register, is represented in the pharmacy activity. Its current activity is in storage, sale and marketing of pharmaceuticals, medical preparations and cosmetics.
CMA approved, on April 3, the application submitted by the company to offer its shares on Nomu.
Company Profile |
|
Company |
Al Razi Medical Co. |
Market |
Nomu-Parallel Market |
Core activities |
Pharmacy activities |
Capital |
SAR 15.2 mln |
IPO Summary |
|
Issue Percentage |
20% |
Offered shares |
304,000 |
Minimum limit |
10 shares |
Maximum limit |
74,000 shares |
Offer period |
June 4-6, 2023 |
Final Allocation |
June 11, 2023 |
Refund (if any) |
June 12, 2023 |
Company Shareholders |
||||
Shareholders |
Before IPO |
Post-IPO |
||
Number of Shares (‘000) |
Ownership (%) |
Number of Shares (‘000) |
Ownership (%) |
|
Yousuf Abdullah Yousuf Al Arini |
1141.9 |
75.1% |
994.9 |
65.5% |
Mohammed Abdullah Suleiman Al Saghir |
29.2 |
1.9% |
6.9 |
0.5% |
Fawziya Suleiman Abdullah Al Saghir |
24.0 |
1.6% |
13.9 |
0.9% |
Mohammed Abdullah Suleiman Ebeid |
22.1 |
1.5% |
12.8 |
0.8% |
Others |
302.8 |
19.9% |
187.5 |
12.3% |
QFIs |
-- |
-- |
304.0 |
20.0% |
Total |
1520.0 |
100% |
1520.0 |
100% |
Additional Information |
|
Financial Advisor |
Team One Co. |
Lead Manager |
Derayah Financial |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}